Pharmacokinetics and Inflammatory-Fluid Penetration of Moxifloxacin following Oral or Intravenous Administration
AUTOR(ES)
Wise, Richard
FONTE
American Society for Microbiology
RESUMO
A single 400-mg oral or intravenous (i.v.) dose of moxifloxacin was given to each of eight healthy male volunteers, and 6 weeks later the dose was administered by the other route. The concentrations of the drug in plasma, cantharidin-induced inflammatory fluid, and urine were measured over the subsequent 24 h. The mean maximum concentrations observed in plasma were 4.98 μg/ml after oral dosing and 5.09 μg/ml after i.v. dosing. The mean maximum concentrations attained in the inflammatory fluid were 2.62 and 3.23 μg/ml, respectively. The mean elimination half-lives from plasma were 8.32 and 8.17 h, respectively. The overall penetration into the inflammatory fluid was 103.4 and 104.2%. Over 24 h 15% of the drug was recovered in the urine when administered by either route.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=89310Documentos Relacionados
- Pharmacokinetics and Inflammatory Fluid Penetration of Intravenous Daptomycin in Volunteers
- Pharmacokinetics and inflammatory fluid penetration of sparfloxacin.
- Pharmacokinetics and Inflammatory Fluid Penetration of Clinafloxacin
- Pharmacokinetics and tissue penetration of ampicillin and brobactam following oral administration of 2085P.
- Pharmacokinetics of isepamicin following a single administration by intravenous infusion or intramuscular injections.
